Administration of anti-interleukin-2rα monoclonal antibody in bronchiolitis obliterans syndrome after lung transplantation [7]

Transplantation

Volumn 75, Issue 10, 2003, Pages 1767-1769

  Ding, Isabelle Beatrice ^a   Baumgartner, Rainer Anton ^a   Schwaiblmair, Martin ^a   Behr, Jürgen ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

BRONCHIOLITIS; DRUG EFFICACY; DRUG SAFETY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION; LETTER; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BRONCHIOLITIS OBLITERANS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG TRANSPLANTATION; RECEPTORS, INTERLEUKIN;

EID: 0038392952     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000062537.80653.FE     Document Type: Letter

References (5)

1. Duncan SR, Leonard C, Theodore J, et al. Oligoclonal CD4+ T cell expansions in lung transplant recipients with obliterative bronchiolitis. J Resp Crit Care Med 2002; 165: 1439-1444.
2. Uchiyama T, Nelson DL, Fleisher TA, et al. A monoclonal antibody (antiTac) reactive with activated and functionally mature human T cells. J Immunol 1981; 126: 1398-1403.
3. Hakimi J, Chizzonite R, Luke DR, et al. Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys. J Immunol 1991; 147: 1352-1359.
4. Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998; 338: 161-5.
5. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21(3): 297-310.